Seelos Therapeutics (SEEL.Q) Proxy Filing summary

Executive summary

• Annual Meeting of Stockholders postponed from September 27, 2024, to October 25, 2024, due to anticipated lack of quorum and to allow more time for proxy solicitation.

• Record date for voting remains August 19, 2024; previously cast votes will be counted unless changed or revoked.

• Forward-looking statements highlight risks including stockholder approval, capital raising, and stock price volatility.

Voting matters and shareholder proposals

• Board unanimously recommends voting FOR all director nominees and proposals as outlined in the proxy statement.

• Stockholders are encouraged to vote promptly to ensure their shares are represented.

Board of directors and corporate governance

• Directors, executive officers, and employees are participating in the proxy solicitation.

• Information on director and executive officer holdings is available in the definitive proxy statement and SEC filings.